Health
A nanoscaffolding approach for rapid design of highly immunogenic SARS-CoV-2 vaccines – News-Medical.net
A research group from Slovenia, Switzerland, and Germany shows how nanoscaffolded assemblies may neutralize interaction between the SARS-CoV-2 spike protein and cell receptor, providing adequate protection in a surrogate infection assay and warranting the adv…
A research group from Slovenia, Switzerland, and Germany shows how nanoscaffolded assemblies may neutralize interaction between the SARS-CoV-2 spike protein and cell receptor, providing adequate protection in a surrogate infection assay and warranting the advance of such platforms in the pursuit for the effective vaccine. Their results are currently available on bioRxiv* preprint server.
Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) is a causative agent of the ongoing COVID-19 pa…
-
Business22 hours agoWhy the Betashares Nasdaq 100 ETF could be a perfect buy and hold pick
-
Noosa News21 hours agoNew FLC President has regional lens – Proctor
-
Business23 hours agoDoes Macquarie rate BHP shares a buy after its FY25 results?
-
General19 hours agoMigrants raise concerns over Australia’s English tests for visa applicants